Notice

Early Contract Program about AACPi and ACPi

Based on domestic and overseas market research, robots or CSTDs that were developed for preparation are not ultimately overcome Anticancer drug exposure (inevitable exposure in the process of extracting from an anticancer drug container to B with a syringe, needle, CSTD used for preparation, etc.) and selective dispensing, syringe, needle, CSTD, and Medical wastes, etc.. But it was confirmed that AACPi and ACPI were absolutely necessary because the work stress and workload of the formulator was too much for the work that had to be done force majeure such as problems. AACPi and ACPi have come to understand that there is no alternative both domestic and overseas market.

The preparation equipment AACPi and ACPi includes barcode scanner and label printer functions and then, when the dispenser orders from the control panel (PC) based on patient information, prescription information, and dispensing information, it is automatically dispensed and Barcode label including preparation information is printed by the scanner and the prepared container and kit set are automatically packaged without being separated, and the function of the automated equipment is to attach a bar code to the packaging container. The scanner of H-100 Infusion pump which is linked HIS can scan the bar code of the container prepared and the bar code of patient information attached to the patient arm and these functions will be minimized human error as much as possible. We intend to complete product development and launch within the first quarter of 2021.

First of all, with the existing Anyfusion V100 model, as a prototype containing AACPi and ACPi functions, we are going to conduct the demos with sequentially at 42 senior hospitals to help understand the concept of AACPi and ACPi from September.

We want to receive advice from hospital officials, reflect them in product development, receive early orders with AACPi and ACPi of the spec suitable for the hospital, and proceed with supply contracts in order of order. If possible, the company's goal is to sign all of the higher-level hospitals within this year. In addition, overseas market research is also being conducted, and unlike Korea, which is hospitalized, but in some countries, it was found that injections are performed at the oncology clinic depending on the type of cancer patient. We have provided data to our existing customers, such as the US, Japan, Germany, Saudi Arabia, Iran, and Dominica, and are negotiating with the US, Saudi Arabia, and Iran.

We are preparing to enter the overseas market in earnest from the point of the end of COVID-19, and we intend to complete all preparations for export from the second half of next year.

Thank you.


Next Anyfusion Platform Business
Prev Selected as Government support project for the usability test of FDA for Anyfusion